產(chǎn)品詳情
簡單介紹：
Anti-OR8B2/OR8B3抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-OR8B2/OR8B3抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-OR8B2/OR8B3
Cat. Number:
Anti-OR8B2/OR8B3抗體KL-17993R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptorsAnti-OR8B2/OR8B3抗體 (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. [provided by RefSeq, Jul 2008]
Also known as:
OR8B2 + OR8B3; Olfactory Anti-OR8B2/OR8B3抗體receptor 8B2; Olfactory receptor 8B3; Olfactory receptor OR11 309; Olfactory receptor OR11 310; Olfactory receptor OR11 311; Olfactory receptor, family 8, subfamily B, member 2; Olfactory receptor, family 8, subfamily B, member 3; OR11 309; OR11 310; OR11 311.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH conjugated Anti-OR8B2/OR8B3抗體synthetic peptide derived from human OR8B2/OR8B3.
●
Predicted Molecular Weight: 35kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-OR8B2/OR8B3抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-OR8B2/OR8B3抗體
Optimal working dilutions must be determined by the end user.
